Semaglutide found to reduce body weight regardless of patient characteristics
New experimental drug cagrilintide (AM833), when combined with emaglutide, shows potential for treatment of obesity
13 May 2021Vaccinating children against SARS-CoV-2
13 May 2021Semaglutide found to reduce body weight regardless of patient characteristics
New research presented at this year’s European Congress on Obesity (held online, 10-13 May) shows that treatment with the drug semaglutide reduces body weight in adults with overweight or obesity, regardless of their baseline characteristics.
